Investors in Ar

Silicon Roundabout Ventures is a community-driven venture capital firm specializing in backing Deep Tech and Big Data startups at the pre-seed and seed stages. Leveraging a robust community of 15,000 founders and engineers, they support startups through live pitching competitions that have showcased winners now collectively valued at over £6 billion. Silicon Roundabout Ventures aims to identify and nurture innovative startups in technology, providing strategic support and access to a vast network to accelerate their growth and success in the global market.

Selvedge Venture is a venture capital advisory and management firm headquartered in London, UK. Specializing in providing strategic guidance and management services, Selvedge Venture supports early-stage and growth-stage companies in navigating the complex landscape of venture capital. With a focus on fostering innovation and sustainable growth, Selvedge Venture aims to empower entrepreneurs and startups to achieve their full potential in the competitive global market.

Sustainable Future Ventures (SFV) is a venture capital firm dedicated to investing in technology companies that are leading the way towards a more sustainable built environment. Leveraging deep relationships within the real estate sector, SFV identifies and supports innovative technologies that address environmental, economic, and social sustainability challenges across the real asset value chain. SFV's investment focus spans from technologies that influence how new assets are built and the materials used, to transforming transactions and operational practices within the built environment. They operate globally, investing from late seed to Series B stages, and are supported by PATRIZIA, enhancing their ability to drive impactful change through strategic investments in transformative technologies.

Zinal Growth is a global investment firm dedicated to empowering exceptional founders in their mission to build generational technology companies. With a focus on providing strategic capital and operational support, Zinal Growth partners with visionary entrepreneurs who are driving innovation across various sectors. By fostering long-term partnerships, Zinal Growth aims to accelerate the growth and success of pioneering ventures that have the potential to make a lasting impact on the global stage.

Plural Platform is an early-stage investment fund launched in June 2022, dedicated to supporting ambitious founders who are leveraging technology to drive global change. We aim to provide serious founders in Europe with investors who bring extensive company-building experience to match our ambition. Our mission is to achieve GDP-level impact in Europe, mitigate systemic risks, and reduce the global opportunity gap through our portfolio companies.

Emso Asset Management is an alternative asset manager specializing in investing across emerging markets fixed income strategies. The firm focuses on identifying attractive investment opportunities in sovereign debt, corporate bonds, currencies, and related instruments within emerging markets. Emso Asset Management employs a disciplined investment approach that integrates rigorous research, fundamental analysis, and risk management to generate alpha and preserve capital. The firm serves institutional investors, including pension funds, endowments, and sovereign wealth funds, by offering diversified investment solutions designed to deliver attractive risk-adjusted returns. With a commitment to transparency, integrity, and client-centric service, Emso Asset Management aims to provide investors with access to emerging markets and capitalize on opportunities arising from global economic trends and market dynamics.

European Equity Partners specializes in providing capital to high-growth companies in Northern Europe seeking external funding. As a dedicated investment firm, European Equity Partners focuses on identifying and supporting promising businesses with innovative ideas and scalable business models. Their investment strategy is centered around fostering growth and maximizing potential through strategic financial support and operational guidance. By leveraging their expertise and network, European Equity Partners aims to empower entrepreneurs and drive sustainable economic development in Northern Europe. They play a pivotal role in fueling innovation and entrepreneurship by offering tailored financial solutions and fostering long-term partnerships with ambitious companies poised for expansion.

Eurovestech PLC is an AIM-listed pan-European development capital fund that specializes in investing in high-technology enterprises. The firm focuses on identifying and supporting innovative companies across Europe with high growth potential, particularly in sectors such as technology and digital media. Eurovestech provides strategic development capital to help these enterprises accelerate their growth, expand their market presence, and achieve their strategic objectives. As a publicly listed company on the AIM market, Eurovestech offers investors the opportunity to participate in the growth of promising high-tech businesses through transparent and regulated investment vehicles. The firm's investment strategy emphasizes active management and value creation, aiming to maximize shareholder value while supporting the development of transformative technologies and businesses.

Evolvient Capital, we focus on partnering with leadership teams from startups to scale-ups. We leverage our experience to support business growth and development, emphasizing learning from our past mistakes to guide leaders in building successful businesses and realizing their full potential.

Exceptional Ventures, we are a London-based venture capital firm dedicated to investing in high-impact startups that contribute to improving the world we live in. Our mission is clear: we aim to help people live healthier, happier, and longer lives while promoting a sustainable planetary ecosystem. Through our debut fund, EV Fund 1, which targets £20 million in size, we are actively building a portfolio of 40 early-stage startups over the next three years. Our focus areas include HealthTech, FoodTech, and Financial Health, primarily within the UK/EU region while opportunistically exploring opportunities globally. Our founders, Matt Cooper and Paolo Pio, bring a wealth of experience to Exceptional Ventures. Matt's background includes co-founding Capital One Bank in the US, Tandem Bank in the UK, and chairing Octopus Group for over two decades. Paolo, formerly a Silicon Valley Software Engineer and Tech Executive, transitioned into venture capital as MD Europe at Joyance Partners, a prominent US HealthTech VC fund. With a combined portfolio of over 200 invested startups, we leverage our deep industry knowledge and extensive network to support entrepreneurs and drive positive societal impact through strategic investments.

Leafy Tunnel is a Venture Capital firm dedicated to investing in alternative medicine, focusing on the transformative potential of medicinal cannabis and psychedelics. Through direct investments, we aim to foster the growth of pioneering companies leading research, development, and commercialization in these sectors. In controlled therapeutic settings, these modalities offer promise in unraveling the mysteries of the mind, revealing pathways to self-discovery and emotional healing. Alternative medicine, particularly in psychedelic and cannabis therapies, challenges traditional healing approaches, merging ancient wisdom with modern science to explore the limitless potential of human consciousness. This convergence forms a new paradigm where art, music, and culture blend with therapeutic practices, enhancing self-exploration and emotional liberation. At Leafy Tunnel, we leverage our extensive network, expertise, and resources to collaborate with entrepreneurs and startups that share our vision for the future of alternative medicine. Our investment approach emphasizes rigorous analysis, honest feedback, and a commitment to ethical and sustainable practices.

LifeArc is an independent life science medical research charity dedicated to improving positive patient outcomes globally. As a pioneering organization, LifeArc focuses on translating cutting-edge biomedical research into tangible benefits for patients and society. Their mission spans across the entire medical innovation pipeline, from early-stage discovery to development and commercialization. LifeArc collaborates with academic institutions, research organizations, and industry partners to accelerate the translation of scientific discoveries into new treatments and therapies. Through strategic funding, expertise, and partnerships, LifeArc supports innovative projects that address unmet medical needs and advance medical science. Committed to making a significant impact on healthcare, LifeArc plays a crucial role in driving innovation, fostering collaboration, and ultimately, improving patient lives worldwide.